Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Tsumura & Co ( (JP:4540) ) is now available.
Tsumura & Co. has announced the intermediate results of its share repurchase program, which was initiated following a board resolution in February 2025. As of April 30, 2025, the company has repurchased 707,300 shares at a total cost of approximately 3.03 billion yen, reflecting its strategic efforts to enhance shareholder value and optimize capital structure.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, specializing in the production and distribution of traditional Japanese Kampo medicines. The company is focused on leveraging its expertise in herbal medicine to maintain a strong market position in Japan and expand its influence globally.
YTD Price Performance: -6.24%
Average Trading Volume: 369,950
Technical Sentiment Signal: Buy
Current Market Cap: Yen332.6B
Find detailed analytics on 4540 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue